Supreme Court takes up state bans on transgender athletes in girls' and women's sports

Supreme Court takes up state bans on transgender athletes in girls’ and women’s sports

Supreme Court ruling on gender-affirming care White House reacts to Supreme Court ruling on gender-affirming care for transgender minors 04:22 Washington — The Supreme Court on Thursday said it will consider whether states can prohibit transgender athletes from participating in girls’ and women’s sports, setting up a high-profile clash that could have far-reaching implications across…

Read More
Chairman of Engro, Hussain Dawood, Appreciates Enduring China-Pakistan Partnership at WEF summit with Chinese Premier, Li Qiang

Chairman of Engro, Hussain Dawood, Appreciates Enduring China-Pakistan Partnership at WEF summit with Chinese Premier, Li Qiang

By Rafiq Vayani KARACHI: Chairman of Engro, Mr. Hussain Dawood, was invited to speak at a Special Dialogue with Li Qiang, Premier of the People’s Republic of China, during the World Economic Forum’s 16th Annual Meeting of the New Champions. During the session Mr. Dawood reaffirmed the enduring all-weather friendship between China and Pakistan. He…

Read More
Employers added 147,000 jobs in June as U.S. labor market continues to defy expectations

Employers added 147,000 jobs in June as U.S. labor market continues to defy expectations

Employers across the U.S. added 147,000 jobs in June, with the labor market remaining resilient despite slowing economic growth this year. The numbers Job growth was stronger than expected in June. Payroll gains sailed past the 115,000 predicted by economists polled by financial data firm FactSet. The unemployment rate ticked down to 4.1% from 4.2% in…

Read More
2 Beaten-Down Stocks With Massive Upside Potential

2 Beaten-Down Stocks With Massive Upside Potential

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific issues that predate this year. Take, for instance, CRISPR Therapeutics (CRSP 6.51%) and Viking Therapeutics (VKTX 3.94%), two mid-cap biotech companies that have lagged broader equities over the trailing-12-month period. Even with these poor performances, however,…

Read More